Breadcrumb

CIM News

$2M to the MUHC Foundation for precision cancer care

BMO gift will help cancer researchers at the RI-MUHC develop the hospital’s precision oncology program

RI-MUHC research team leads new consortium to make healthcare data more accessible

The new Quebec SmartCare Consortium has received $10M to break down data silos and increase the...

Promising COVID-19 therapeutic drug to start phase 3 clinical trial in the United States

Recruitment of first U.S.-based patients in dapsone trial has started

RI-MUHC team studies a novel, fully automated insulin delivery system

A new publication in Lancet Digital Health describes an important step that may improve glucose control and quality of life for people with type 1...

RI-MUHC researchers contribute to global study of babies born with birth defects

A new study published in The Lancet finds that survival for babies born with a birth defect – otherwise known...

New Quebec study evaluates long-term complications of COVID-19

RI-MUHC researcher Thao Huynh has been awarded a grant from Pfizer to conduct the IMPACT QUEBEC COVID-19 Long Haul Study

Fever is now more often a sign of serious bacterial infection

RI-MUHC researchers advocate for extra vigilance with feverish infants as new study shows startling numbers of serious bacterial infections during...

Dr. Jonathan Afilalo wins Prize for Outstanding Emerging Researchers

Fundamentally changing how cardiologists approach older patients

Services for clinical research are going strong at the Centre for Innovative Medicine

Experts at the CIM technology platforms are on site to support clinical research

Explore news and events at the RI-MUHC